| |
|
|
|
Arcadia Biosciences Inc.  
|
|
3.65 0.04 (0.01%) |
05-22 16:00 |
|
Open: |
3.75 |
Pre close: |
3.61 |
Target:
|
5.38 
|
|
High: |
3.75 |
Low: |
3.5958 |
Resistance:
|
4.60
5.32
|
|
Volume: |
153,310 |
Market Cap: |
37M |
Support:
|
3.45
2.87
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.72
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
4.23 |
Signal(12,26,9): |
0.12 |
|
MA(100): |
4.18 |
Stochastic Oscillator |
%K(14,3):
|
11.77 |
|
MA(250): |
4.56 |
%D(3): |
14.51 |
|
Average Volume(K) |
3-Month: |
18788
|
52-Week |
High:
|
10.20 |
|
10-Days: |
32940 |
Low: |
1.82 |
|
RSI |
RSI(14):
|
42.17 |
Change(%): |
-29.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.866 |
Return on Equity (ttm) |
-215.3 |
Shares Out. (M) |
10.05 |
|
EPS Est. Current Year |
-0.360 |
Return on Assets (ttm) |
-50.6 |
Shares Float (M) |
7.01 |
|
EPS Est. Next Year |
-0.220 |
PEG Ratio |
0.00 |
% Held by Insiders |
19.04 |
|
EPS Est. Next Quarter |
-0.080 |
Qtrly Rev. Growth |
95.6 |
% Held by Institutions |
13.04 |
|
Forward EPS |
-4.530 |
Gross Profit (p.s.) |
-0.678 |
Shares Short (K) |
504 |
|
Book Value (p.s.) |
1.270 |
EBITDA (p.s.) |
-2.161 |
P/E |
-1.96 |
|
Sales Per Share |
0.131 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.87 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-22.50 |
P/S |
27.79 |
|
Operating Margin |
-1663.11 |
Levered Free Cash Flow
(M) |
-15.87 |
P/CF |
-1.63 |
|
|
|
|
|
|
